HOLLER FRANK A sold 6.7% of their position (9.44K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $87.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/18/2019ACC: 0001209191-19-050136
+5.56K
Net shares
Net buyer
$87.8K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
15K acquired · 9.44K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
−5.07K
Price / share
$9.32
Trade value
$47.24K
% of position
3.6%
9/17/2019
141.20K→136.13K
Common Shares
Direct
Shares
−4.37K
Price / share
$9.28
Trade value
$40.54K
% of position
3.2%
9/18/2019
136.13K→131.76K
Total
Net shares
−9.44K
Net value
-$87.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/17/2019 | S · Sale | −5.07K | $9.32 | $47.24K | 3.6% | 141.20K | 136.13K |
| Common Shares Direct | 9/18/2019 | S · Sale | −4.37K | $9.28 | $40.54K | 3.2% | 136.13K | 131.76K |
| Total | −9.44K | -$87.78K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
15K shares
Shares
+15K
Strike price
9.44
Held after
15K
Exercisable
—
9/16/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares15K shares | 9/16/2019 | A · Award | +15K | 9.44 | — | 15K |